10-44373416-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001277990.2(CXCL12):c.110-326G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0466 in 1,349,348 control chromosomes in the GnomAD database, including 1,820 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.039 ( 149 hom., cov: 34)
Exomes 𝑓: 0.048 ( 1671 hom. )
Consequence
CXCL12
NM_001277990.2 intron
NM_001277990.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.63
Genes affected
CXCL12 (HGNC:10672): (C-X-C motif chemokine ligand 12) This antimicrobial gene encodes a stromal cell-derived alpha chemokine member of the intercrine family. The encoded protein functions as the ligand for the G-protein coupled receptor, chemokine (C-X-C motif) receptor 4, and plays a role in many diverse cellular functions, including embryogenesis, immune surveillance, inflammation response, tissue homeostasis, and tumor growth and metastasis. Mutations in this gene are associated with resistance to human immunodeficiency virus type 1 infections. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 10-44373416-C-T is Benign according to our data. Variant chr10-44373416-C-T is described in ClinVar as [Benign]. Clinvar id is 1237787.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0914 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0390 AC: 5932AN: 152190Hom.: 151 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
5932
AN:
152190
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0476 AC: 56944AN: 1197040Hom.: 1671 AF XY: 0.0502 AC XY: 30263AN XY: 602506 show subpopulations
GnomAD4 exome
AF:
AC:
56944
AN:
1197040
Hom.:
AF XY:
AC XY:
30263
AN XY:
602506
Gnomad4 AFR exome
AF:
AC:
617
AN:
27748
Gnomad4 AMR exome
AF:
AC:
834
AN:
37812
Gnomad4 ASJ exome
AF:
AC:
1928
AN:
23900
Gnomad4 EAS exome
AF:
AC:
9
AN:
36018
Gnomad4 SAS exome
AF:
AC:
7955
AN:
76100
Gnomad4 FIN exome
AF:
AC:
1841
AN:
50378
Gnomad4 NFE exome
AF:
AC:
40882
AN:
888412
Gnomad4 Remaining exome
AF:
AC:
2422
AN:
51354
Heterozygous variant carriers
0
2879
5758
8637
11516
14395
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
1364
2728
4092
5456
6820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0390 AC: 5933AN: 152308Hom.: 149 Cov.: 34 AF XY: 0.0390 AC XY: 2907AN XY: 74468 show subpopulations
GnomAD4 genome
AF:
AC:
5933
AN:
152308
Hom.:
Cov.:
34
AF XY:
AC XY:
2907
AN XY:
74468
Gnomad4 AFR
AF:
AC:
0.0220475
AN:
0.0220475
Gnomad4 AMR
AF:
AC:
0.0294617
AN:
0.0294617
Gnomad4 ASJ
AF:
AC:
0.0794931
AN:
0.0794931
Gnomad4 EAS
AF:
AC:
0.00135817
AN:
0.00135817
Gnomad4 SAS
AF:
AC:
0.0987552
AN:
0.0987552
Gnomad4 FIN
AF:
AC:
0.0385919
AN:
0.0385919
Gnomad4 NFE
AF:
AC:
0.048002
AN:
0.048002
Gnomad4 OTH
AF:
AC:
0.0345317
AN:
0.0345317
Heterozygous variant carriers
0
299
597
896
1194
1493
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
110
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at